Premium
The influence of serum screening on the amniocentesis rate in women of advanced maternal age
Author(s) -
Beekhuis J. R.,
de Wolf B. T. H. M.,
Mantingh A.,
Heringa M. P.
Publication year - 1994
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.1970140310
Subject(s) - amniocentesis , medicine , advanced maternal age , obstetrics , pregnancy , age groups , population , singleton , gynecology , prenatal diagnosis , demography , fetus , genetics , environmental health , sociology , biology
We investigated the effect of maternal serum screening on the amniocentesis (AC) rate in women of advanced maternal age. The AC rate after maternal serum screening was compared in two groups of women with a singleton pregnancy, 855 women of 30–35 years and 98 of 36 years and older. In our population, 34·1 per cent of the women of 36 years or older were ‘screen‐positive’ for Down syndrome. Only 41·2 per cent of these women chose to undergo AC as opposed to 88·2 per cent in the younger age group. Within the older age group, the tendency to avoid AC increased with increasing age. Maternal serum screening led to a significant decrease in the AC rate in the older women. In this group, a comparison between the ‘ a priori ’ and the calculated risk might have had more influence on the decision to undergo AC than being screen‐positive or screen‐negative as such. We conclude that maternal serum screening had a major effect on the AC rate in women of advanced maternal age. This is of importance in a society in which the average maternal age is steadily increasing.